Abstract
CY-A is a potent immunosuppressive agent and can prevent graft rejection. In our experience hirsutism and viral infections are marked. Lymphomas may be more common in CY-A-treated patients than in those treated conventionally. Smaller doses of CY-A given for shorter periods before conversion to conventional treatment may be a better way to use this new agent.
Original language | English |
---|---|
Pages (from-to) | 365-367 |
Number of pages | 3 |
Journal | Transplantation Proceedings |
Volume | 13 |
Issue number | 1 Pt 1 |
Publication status | Published - Mar 1981 |